Filing Flows › Bio Key International (BKYI) › Q1 2025
Bio Key International (BKYI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Bio Key International (BKYI) reported revenue of $1.6M for the first quarter 2025 (Q1 2025), -26% from a year earlier and +10% from the quarter before. Operating margin was -39.9%, net loss $737K (45.8% of revenue).
Bio Key International, Q1 2025: revenue $1.6M (-26% year over year), operating margin -39.9%, net loss $737K, operating cash flow −$835K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | +10% | -26% |
| Operating profit | −$641K | — | — |
| Net earnings | −$737K | — | — |
| Operating cash flow | −$835K | — | — |
What changed
Revenue was $1.6M in Q1 2025, down 26% year over year and up 10% from the previous quarter. License was the largest line at 68% of revenue. License lost $852K year over year (down 44%), 148% of the total change.
Gross margin was 82.6%, down 3.7 points from a year earlier. Operating costs exceeded revenue by $641K, an operating margin of -39.9%. Operating expenses fell 18% while revenue fell 26%. The quarter ended with a net loss of $737K, narrower than the previous quarter's $1.4M loss.
Operating cash flow was −$835K. Non-cash charges added back $98K of depreciation and amortization and $52K of share-based compensation. Working capital and other items used $249K. Capital expenditures of $5K exceeded it, leaving free cash flow of −$840K.
Questions
What was Bio Key International's revenue in the first quarter 2025?
Bio Key International (BKYI) reported revenue of $1.6M for the first quarter 2025 (Q1 2025), -26% from a year earlier and +10% from the quarter before.
Was Bio Key International profitable in the first quarter 2025?
Operating loss was $641K (-39.9% of revenue) and net loss $737K.